BRIEF-Mylan invalidates Allergan's patents on Restasis By: Reuters: Company News October 16, 2017 at 21:34 PM EDT * U.S. district court for Eastern District of Texas issued decision finding asserted claims of patents relating to Restasis invalid Read More >> Related Stocks: Allergan Plc Mylan